We present the first two fulminant cases of pulmonary melioidosis in febrile neutropenic patients with acute and varied presentations seen in our institution and their fatal outcome. A high index of suspicion coupled with microbiological confirmation can facilitate the administration of the appropriate therapy in cases of melioidosis that differ from other bacterial infections in terms of presentation and the response to antimicrobials.
Get full access to this article
View all access options for this article.
References
1.
MukhopadhyayC, ChawlaK, KrishnaS, NagalakshmiN, RaoPS, BairyI.Emergence of Burkholderia Pseudomallei and pandrug resistant non-fermenters from southern Karnataka, India.Royal Soc Trop Med Hygiene2008; 102: S12–S17.
2.
ChengAC, CurrieBJ.Melioidosis: epidemiology, pathophysiology and management.Clin Microbiol Rev2005; 18: 383–416.
3.
MaschmeyerG, NoskinGA, RibaudP, SepkowitzKA.Changing patterns of infections and antimicrobial susceptibilities.Oncology2000; 14 (Suppl. 6): 9–16.
4.
HealeyT, Selva-NayagamS.Retrospective review of febrile neutropenia in the Royal Darwin Hospital, 1994-99.Int Med J2001; 31: 406–12.
5.
ChaowagulW, WhiteNJ, DanceDAB.Melioidosis: a major cause of community-acquired septicemia in northern Thailand.J Infect Dis1989; 159: 890–9.
6.
JennyAW, LumG, FischerDA, CurrieBJ.Antibiotic susceptibilities of Burkholderia pseudomallei from tropical northern Australia and implications for therapy for melioidosis.Int J Animicrob Agents2001; 17: 109–13.
